QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. They are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus their programs on tackling specific disease-causing mechanisms.

Biotechnology

QurAlis

QurAlis' headquarters in Cambridge, MA, United States

Kasper Roet

Chris Thomajan

Jason Parker Brown

Meredith Ball

Manoj Malhotra

Guzide Adhikari (Icke)

Hagen Cramer

Vikas Sharma

Daniel Elbaum

Brian J. Wainger

Christopher Shaw

Amy Schulman

Luc Dochez

Bernhardt L. Trout

Clifford Woolf

Kevin Eggan

Matthew Kiernan

Michelle Hastings

Johannes Fruehauf

Michael Hutton

Laia Crespo

Cillian King

Sudir Agrawal

Anne C. Whitaker

Philip Van Damme

Ammar Al-Chalabi

Dame Pamela J. Shaw

The Research and Development Team at QurAlis is dedicated to advancing the understanding and treatment of ALS by investigating the underlying mechanisms of the disease. Comprising a diverse group of scientific experts, the team collaborates to develop targeted therapeutics, design and conduct experiments, and analyze data to identify potential pathways for intervention. Their work aims to translate innovative research into precision medicine solutions that improve the lives of ALS patients.

Research and Development Team

The Leadership Team at QurAlis is responsible for guiding the company’s strategic direction in the pursuit of innovative therapeutics for ALS. Comprising key executives across medical, scientific, financial, production, and business disciplines, the team collaborates to align research initiatives with market needs, ensure operational efficiency, and drive organizational growth while focusing on delivering impactful solutions to combat ALS.

Leadership Team

The Finance and Administration Team at QurAlis is responsible for overseeing the company’s financial planning, budgeting, and reporting processes to ensure sound fiscal management. They handle operational administration, facilitate efficient resource allocation, and support strategic initiatives to drive the organization’s mission in developing precision therapeutics for ALS. This team plays a crucial role in maintaining financial health while ensuring that administrative functions align with the company’s goals.

Finance and Administration Team

The Clinical Operations Team at QurAlis is responsible for managing and overseeing clinical trials that test precision therapeutics for ALS. This team ensures adherence to regulatory standards, coordinates clinical supply logistics, and implements quality assurance measures to uphold the integrity of the studies. By collaborating closely with various stakeholders, they aim to effectively support the development pipeline and enhance the understanding of ALS treatment mechanisms.

Clinical Operations Team

The Regulatory Affairs and Quality Assurance Team at QurAlis is responsible for ensuring that all therapeutic developments meet regulatory standards and quality benchmarks throughout the drug development process. This team collaborates closely with clinical and research teams to navigate the regulatory landscape, prepare necessary documentation for submissions, and implement quality assurance measures that uphold Good Laboratory Practices (GLP) and Good Clinical Practices (GCP). Their work is critical in facilitating the advancement of precision therapeutics for ALS while ensuring compliance and safety.

Regulatory Affairs and Quality Assurance Team

QurAlis

Org chart

Board & advisors

Teams

Research and Development Team

Leadership Team

Finance and Administration Team

Clinical Operations Team

Regulatory Affairs and Quality Assurance Team

Offices

QurAlis

Org chart

Board & advisors

Teams

Research and Development Team

Leadership Team

Finance and Administration Team

Clinical Operations Team

Regulatory Affairs and Quality Assurance Team

Offices

Related companies